Peptide Reference
Dihexa
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide)
A potent nootropic peptide analog of angiotensin IV with exceptional cognitive-enhancing and neurogenic properties. Seven orders of magnitude more potent than BDNF.
Status
research
Category
cognitive
Typical cost
$100-200/vial (10mg)
Mechanism
Potent activator of hepatocyte growth factor (HGF) with exceptional affinity for HGF receptors. Promotes synaptogenesis, neurogenesis, and enhances cognitive function far beyond other nootropics.
Potential benefits
- Extreme potency
- Neurogenesis
- Synaptogenesis
- Cognitive enhancement
- Memory improvement
Reported side effects
- Limited human data
- Potentially too powerful
- Unknown long-term effects
- High risk experimental
Common dosing references
subcutaneous
8-20mcg · Daily
4-8 weeks
Research notes
Dihexa HGF activation
2012
Demonstrated 7 orders of magnitude greater potency than BDNF for synaptogenesis
Dihexa Alzheimer's potential
2013
Reversed cognitive deficits in Alzheimer's animal models
Regulatory and sourcing notes
Research chemical only. Not FDA-approved. Extremely potent experimental nootropic.
Research peptide. Extremely potent. Very experimental. High risk/reward profile.
Find peptide-aware clinics
Use location pages to compare clinics with peptide therapy signals and verify clinical oversight before treatment.
Related peptides